Botulinum toxin in the treatment of focal hyperhidrosis

References

• Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. Can. Assoc. Med. J.172(1), 69–75 (2005).
   PubMed Web of Science ®Google Scholar
• Hornberger J, Grimes K, Naumann M et al. (Multicenter working group on the recognition, diagnosis, and treatment of primary focal hyperhidrosis). Recognition, diagnosis and treatment of primary focal hyperhidrosis. J. Am. Acad. Dermatol.51(2), 274–286 (2004).
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Saadia D, Polin C, Hague S, Singleton A, Singleton A. Primary hyperhidrosis-evidence for autosomal dominant inheritance. Clin. Auton. Res.13(2), 96–98 (2003).
   PubMed Web of Science ®Google Scholar
• Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J. Vasc. Surg.35(2), 382–386 (2002).
   PubMed Web of Science ®Google Scholar
• Rechardt L, Waris T, Rintala A. Innervation of human axillary sweat glands. Histochemical and electron microscopic study of hyperhidrotic and normal subjects. Scand. Plast. Reconstr. Surg.10(2), 107–112 (1976).
   PubMed Web of Science ®Google Scholar
• Sato G, Kang WH, Saga KT. Biology of sweat glands and their disorders II. Disorders of sweat gland function. J. Am. Acad. Dermatol.20(5 Pt 1), 713–726 (1989).
   PubMed Web of Science ®Google Scholar
• Iwase S, Ikeda T, Kitazawa H, Hakusui S, Sugenoya J, Mano T. Altered response in cutaneous sympathetic outflow to mental and thermal stimuli in primary palmoplantar hyperhidrosis. J. Auton. Nerv. Syst.64(2), 65–73 (1997).
   PubMedGoogle Scholar
• Atkins JL, Butler PE. Hyperhidrosis: a review of current management. Plast. Reconstr. Surg.110(1), 222–228 (2002).
   PubMed Web of Science ®Google Scholar
• Connolly M, de Berker D. Management of primary hyperhidrosis: a summary of the different treatment modalities. Am. J. Clin. Dermatol.4(10), 681–697 (2003).
   PubMed Web of Science ®Google Scholar
• Cameron AE. Specific complications and mortality of endoscopic thoracic sympathectomy. Clin. Auton. Res.1, 131–135 (2003).
   Google Scholar
• Lee PH, Hsieh LF, Hong CZ. Unilateral brachial plexus injury as a complication of thoracoscopic sympathectomy for hyperhidrosis: a case report. Arch. Phys. Med. Rehabil.84(9), 1395–1398 (2003).
   PubMedGoogle Scholar
• Ojimba TA, Cameron AE. Drawbacks of endoscopic thoracic sympathectomy. Br. J. Surg.91(8), 1072-1073 (2004).
   Google Scholar
• Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Sem. Cutan. Med. Surg.20(2), 71–84 (2001).
   PubMed Web of Science ®Google Scholar
• Bushara KO, Park DM. Botulinum toxin and sweating. J. Neurol. Neurosurg. Psychiatry57(11), 1437–1438 (1994).
   PubMed Web of Science ®Google Scholar
• Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Moore D. Botulinum toxins types A and B for brow furrows: preliminary experience with type B toxin dosing. J. Cosmet. Laser Ther.4(1), 15–18 (2002).
   PubMedGoogle Scholar
• Sadick NS, Matarasso SL. Comparison of botulinum toxins A and B in the treatment of facial rhytides. Dermatol. Clin.22(2), 221–226 (2004).
   PubMedGoogle Scholar
• Matarasso SL. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol. Surg.29(1), 7–13 (2003).
   PubMed Web of Science ®Google Scholar
• Sadick NS, Herman AR. Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides. Dermatol. Surg.29(4), 340–347 (2003).
   PubMedGoogle Scholar
• Yamauchi PS, Lowe NJ. Botulinum toxin types A and B: comparison of efficacy, duration and dose ranging studies for the treatment of facial rhytides and hyperhidrosis. Clin. Dermatol.22(1), 34–39 (2004).
   PubMed Web of Science ®Google Scholar
• Odergren T, Hjaltason H, Kaakkola S et al. A double blind, randomised, parallel group study to investigate the dose equivalence of dysport and botox in the treatment of cervical dystonia. J. Neurol. Neurosurg. Psychiatry64(1), 6–12 (1998).
   PubMed Web of Science ®Google Scholar
• Swartling C, Naver H, Pihl-Lundin I, Hagferson E, Vahlquist A. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin. J. Am. Acad. Dermatol.51(5), 739–745 (2004).
   PubMedGoogle Scholar
• Glogau RG. Hyperhidrosis and botulinum toxin A: patient selection and techniques. Clin. Dermatol.22(1), 45–52 (2004).
   PubMedGoogle Scholar
• Lowe N, Campanati A, Bodokh I et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br. J. Dermatol.151(6), 1115–1122 (2004).
   PubMed Web of Science ®Google Scholar
• Baumann L, Frankel S, Welsh E, Halem M. Cryoanalgesia with dichloroethane lessens the pain of botulinum toxin injections for the treatment of palmar hyperhdirosis. Dermatol. Surg.29(10), 1057–1059 (2003).
   PubMedGoogle Scholar
• Blaheta HJ, Vollert B, Zuder D, Rassner G. Intravenous regional anesthesia (Bier’s block) for botulinum toxin therapy of palmar hyperhidrosis is safe and effective. Dermatol. Surg.28(8), 666–671 (2002).
   PubMedGoogle Scholar
• Vadoud-Seyedi J, Simonart T, Heenen M. Treatment of plantar hyperhidrosis with dermojet injections of botulinum toxin. Dermatology201(2), 179–180 (2000).
   PubMedGoogle Scholar
• Benohanian A. Surgical pearl: use of needle-free anesthesia in the treatment of palmar hyperhidrosis with botulinum A toxin. J. Am. Acad. Dermatol.52(6), 1073–1074 (2005).
   PubMed Web of Science ®Google Scholar
• Hayton MJ, Stanley JK, Lowe NJ. A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis. Br. J. Dermatol.149(3), 447–451 (2003).
   PubMedGoogle Scholar
• Fujita M, Mann T, Mann O, Berg D. Surgical pearl: Use of nerve blocks for botulinum toxin treatment of palmar-plantar hyperhidrosis. J. Am. Acad. Dermatol.45(4), 587–589 (2001).
   PubMedGoogle Scholar
• Eisenach JH, Atkinson LD, Fealey RD. Hyperhidrosis: Evolving therapies for a well established phenomenon. Mayo. Clin. Proc.80(5), 657–666 (2005).
   PubMedGoogle Scholar
• Gossot D, Debrosse D, Grunewald D. Endoscopic thoracic sympathectomy for isolated axillary hyperhidrosis. Ann. Derm. Venereol.127(12), 1065–1067 (2000).
   PubMedGoogle Scholar
• Gossot D, Galetta D, Pascal A, Debrosse D et al. Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis. Ann. Thorac. Surg.75(4), 1075–1079 (2003).
   PubMedGoogle Scholar
• Fitzgerald E, Feeley TM, Tierney S. Current treatments for axillary hyperhidrosis. Surgeon2(6), 311–314 (2004).
   PubMedGoogle Scholar
• Naumann MK, Hamm H, Lowe NJ. (Botox Hyperhidrosis Clinical Study Group). Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br. J. Dermatol.147(6), 1218–1226 (2002).
   PubMed Web of Science ®Google Scholar
• Solish N, Benohanian A, Kowalski JW. Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol. Surg.31(4), 405–413 (2005).
   PubMed Web of Science ®Google Scholar
• Heckmann M, Ceballos-Baumann AO, Plewig G; Hyperhidrosis Study Group. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N. Engl. J. Med.344(7), 488–493 (2001).
   PubMed Web of Science ®Google Scholar
• James R, Phillips D, Collin J. Durability of botulinum toxin injection for axillary hyperhidrosis. Br. J. Surg.92(7), 834–835 (2005).
   PubMedGoogle Scholar
• Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis. Dermatol. Surg.24(8), 817–819 (1998).
   PubMedGoogle Scholar
• Naumann M, Hoffmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis; effective treatment with intracutaneous botulinum toxin. Arch. Dermatol.134, 301–304 (1998).
   PubMedGoogle Scholar
• Odderson IR. Axillary hyperhidrosis: treatment with botulinum toxin A. Arch. Phys. Med. Rehabil.79(3), 350–352 (1998).
   PubMedGoogle Scholar
• Odderson IR. Hyperhidrosis treated by botulinum A exotoxin. Dermatol. Surg.24(11), 1237–1241 (1998).
   PubMedGoogle Scholar
• Naumann M, Lowe NJ (on behalf of the Hyperhidrosis Clinical Study Group). Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled study. Br. Med. J.323(7313), 1–4 (2001).
   PubMedGoogle Scholar
• Lowe PL, Cerdan-Sanz S, Lowe NJ. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments. Dermatol. Surg.29(5), 545–548 (2003).
   PubMed Web of Science ®Google Scholar
• Karamfilov T, Konrad H, Karte K, Wollina U. Lower relaps rate of botulinum toxin therapy for axillary hyperhidrosis by dose increase. Arch. Dermatol.136(4), 487–490 (2000).
   PubMedGoogle Scholar
• Heckmann M, Plewig G. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis. A randomized, side-by-side, open-label study. Arch. Dermatol.141(10), 1255–1259 (2005).
   PubMed Web of Science ®Google Scholar
• Goldman A. Treatment of axillary and palmar hyperhidrosis with botulinum toxin. Aesthetic Plast. Surg.24(4), 280–282 (2000).
   PubMed Web of Science ®Google Scholar
• Lapiere JC, Hirsh A, Gordon KB, Cook B. Botulinum toxin type A for the treatment of axillary Hailey-Hailey disease. Dermatol. Surg.26(4), 371–374 (2000).
   PubMed Web of Science ®Google Scholar
• Loscertales J, Arroyo TA, Congregado LM et al. Thoracoscopic sympathectomy for palmar hyperhidrosis. Immediate results and postoperative quality of life. Arch. Bronconeumol.40(2), 67–71 (2004).
   PubMed Web of Science ®Google Scholar
• Lin TS, Kuo SJ, Chou MC. Uniportal endoscopic thoracic sympathectomy for treatment of palmar and axillary hyperhidrosis: analysis of 2000 cases. Neurosurgery51(5), 84–87 (2002).
   PubMed Web of Science ®Google Scholar
• Gossot D, Kabiri H, Caliandro R, Debrosse D, Girard P, Grunenwald D. Early complications of thoracic endoscopic sympathectomy: a prospective study of 940 procedures. Ann. Thorac. Surg.71(4), 1116–1119 (2001).
   PubMedGoogle Scholar
• Naumann M, Bergmann I, Hofmann U, Hamm H, Reiners K. Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in application. Br. J. Dermatol.139(6), 1123–1124 (1998).
   PubMedGoogle Scholar
• Saadia D, Voustianiouk A, Wang AK, Kaufmann H. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Neurology57(11), 2095–2099 (2001).
   PubMedGoogle Scholar
• Benohanian A. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br. J. Dermatol.153(2), 460–461 (2005).
   PubMedGoogle Scholar
• Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J. Am. Acad. Dermatol.42(6), 1026–1029 (2000).
   PubMed Web of Science ®Google Scholar
• Krogstad AL, Skymne A, Pegenius G, Elam M, Wallin BG. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis. Br. J. Dermatol.152(2), 329–333 (2005).
   PubMedGoogle Scholar
• Shelley WB, Talanin NY, Shelley ED. Botulinum toxin therapy for palmar hyperhidrosis. J. Am. Acad. Dermatol.38(2 Pt 1), 227–229 (1998).
   PubMedGoogle Scholar
• Andre P. An easy and effective local anesthesia for treating palmar hyperhidrosis with botulinum toxin injections: the cry-ac system. J. Eur. Acad. Dermatol. Venereol.17(2), 246–247 (2003).
   Google Scholar
• Vadoud-Seyedi J. Treatment of plantar hyperhidrosis with botulinum toxin type A. Int. J. Dermatol.43(12), 969–971 (2004).
   PubMed Web of Science ®Google Scholar
• Sevim S, Dogu O, Kaleagası H. Botulinum toxin-A therapy for palmar and plantar hyperhidrosis. Acta Neurol. Belg.102(4), 167–170 (2002).
   PubMedGoogle Scholar
• Tamura BM, Cuce LC, Souza RL, Levites J. Plantar hyperhidrosis and pitted keratolysis treated with botulinum toxin injection. Dermatol. Surg.30(12 Pt 2), 1510–1514 (2004).
   PubMed Web of Science ®Google Scholar
• Drobik C, Laswaki R. Frey’s syndrome: treatment with botulinum toxin. Acta Otolaryngol.115(3), 459–461 (1995).
   PubMed Web of Science ®Google Scholar
• Laskawi R, Drobik C, Sconebeck C. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating. Laryngoscope108(3), 381–383 (1998).
   PubMedGoogle Scholar
• Arad-Cohen A, Blitzer A. Botulinum toxin treatment for symptomatic Frey’s syndrome. Otolaryngol. Head Neck Surg.122(2), 237–239 (2000).
   PubMedGoogle Scholar
• Kyrmizakis DE, Pangalos A, Papadakis CE, Logothetis J, Maroudias NJ, Helidonis ES. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes. J. Oral Maxillofac. Surg.62(7), 840–844 (2004).
   PubMed Web of Science ®Google Scholar
• Nolte D, Gollmitzer I, Loeffelbein DJ, Holzle F, Wolff KD. Botulinum toxin for treatment of gustatory sweating. A prospective randomized study. Mund. Kiefer. Gesichtscir.8(6), 369–375 (2004).
   PubMedGoogle Scholar
• Kinkelin I, Hund M, Naumann M, Hamm H. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br. J. Dermatol.143(4), 824–827 (2000).
   PubMed Web of Science ®Google Scholar
• Boger A, Herath H, Rompel R, Ferbert A. Botulinum toxin for treatment of craniofacial hyperhidrosis. J. Neurol.247(11), 857–861 (2000).
   PubMedGoogle Scholar
• Sanli H, Ekmekci P, Akbostanci MC. Idiopathic localized crossed (left side of the upper part of the body, right side of the lower part of the body) hyperhidrosis: successful treatment of facial area with botulinum a toxin injection. Dermatol. Surg.30(4), 552–554 (2004).
   PubMedGoogle Scholar
• Klein AW. Contraindications and complications with the use of botulinum toxin. Clin. Dermatol.22, 66–75 (2004).
   PubMedGoogle Scholar
• Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: A double blind, randomized, placebo controlled study. Dermatol. Surg.28(9), 822–827 (2002).
   PubMed Web of Science ®Google Scholar
• Swartling C, Farnstrand C, Abt G, Stalberg E, Naver H. Side effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: a neurophysiological study. Eur. J. Neurol.8(5), 451–456 (2001).
   PubMed Web of Science ®Google Scholar
• Schnider P, Moraru E, Kittler H et al. Treatment of focal hyperhidrosis with botulinum toxin type A: long term follow-up in 61 patients. Br. J. Dermatol.145(2), 289–293 (2001).
   PubMedGoogle Scholar
• Naver H, Swartling C, Aquilonius SM. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up. Eur. J. Neurol.7(1), 55–62 (2000).
   PubMed Web of Science ®Google Scholar
• Alam M, Arndt KA, Dover JS. Severe intractable headache after injection with botulinum. J. Am. Acad. Dermatol.46(1), 62–65 (2002).
   PubMedGoogle Scholar
• Tugnoli V, Eleopra R, Qyatrale R, Capone JG, Sensi M, Gastaldo E. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br. J. Dermatol.147(4), 808–809 (2002).
   PubMed Web of Science ®Google Scholar
• Dressler D, Munchau A, Bhatia KP, Quinn NP, Bigalke H. Antibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses? Eur. Neurol.47(2), 118–121 (2002).
   PubMed Web of Science ®Google Scholar
• Dressler D, Bigalke H, Benecke R. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure. J. Neurol.250(10), 1263–1265 (2003).
   Google Scholar
• Dressler D. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Mov. Disord.19(8), 92–100 (2004).
   PubMed Web of Science ®Google Scholar
• Böni R, Kreyden O, Burg G. Revival of the use of botulinum toxin: application in dermatology. Dermatology4, 287–291 (2000).
   Google Scholar
• Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology45, 1743–1746 (1995).
   PubMed Web of Science ®Google Scholar